Nucleome Therapeutics

Nucleome Therapeutics is a pioneering biotechnology company dedicated to revolutionizing precision medicine through cutting-edge 3D genomics. Focused on complex diseases, Nucleome Therapeutics employs its innovative platform to discover and develop genetically-validated medicines, enhancing drug discovery success rates and more accurately identifying patients who will benefit from treatments.

With an initial focus on inflammatory conditions, Nucleome Therapeutics applies its platform to multiple disease indications and cell types. In addition to building its own robust pipeline, Nucleome Therapeutics actively forges external collaborations in target discovery, target validation, and patient stratification, expanding its reach and impact in the biotechnology landscape. Nucleome Therapeutics is located in Oxford, GB.

Nucleome Therapeutics is committed to advancing healthcare solutions and improving patient outcomes through its groundbreaking work in 3D genomics. We invite the management of Nucleome Therapeutics to create a customized and exclusive company showcase and product listing on our platform, further amplifying their innovative contributions to the field.